Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SAP domain containing ribonucleoprotein pseudogene
- Molecular classification
- Other (Pseudogene; not an active molecular class like a receptor, enzyme, etc.)
01
Overview
The *SAP domain containing ribonucleoprotein pseudogene* (ENSG00000253991) is a genomic DNA sequence similar to the SARNP gene, which encodes a protein with nucleic acid binding activity and functions in mRNA export and cell cycle progression[3]. Pseudogenes generally do not encode functional proteins due to disabling mutations or lack of transcription and translation. There is no evidence for clinical significance or drug interaction for this specific locus, unlike its protein-coding homolog SARNP, which participates in critical cell biology pathways[3]. If the intended query is for a functional, druggable protein, the correct target would be SARNP (SAP domain containing ribonucleoprotein), not the pseudogene.
02
Mechanism of action
None (no drugs act on pseudogenes)
03
Biological functions
None (pseudogenes do not encode functional protein and thus have no direct biological function; the functional parent gene, SARNP, is involved in nucleic acid binding and mRNA export)
04
Disease associations
None (no established disease role for the pseudogene itself; the parent SARNP gene is associated with Exudative Glomerulonephritis and Retinitis Pigmentosa 13)
05
Safety considerations
None (not relevant therapeutically)
06
Interacting drugs
None (pseudogenes are not drug targets)
07
Biomarkers
None (not used as a biomarker)
Beyond the preview
Go deeper on SAP domain containing ribonucleoprotein pseudogene.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SAP domain containing ribonucleoprotein pseudogene.